Literature DB >> 33230340

Will patient-centric sampling become the norm for clinical trials after COVID-19?

Christopher A James1, Matthew D Barfield2, Katie F Maass3, Shefali R Patel4, Melanie D Anderson5.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33230340     DOI： 10.1038/s41591-020-01144-1

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

1.  homeRNA: A Self-Sampling Kit for the Collection of Peripheral Blood and Stabilization of RNA.

Authors:  Amanda J Haack; Fang Yun Lim; Dakota S Kennedy; John H Day; Karen N Adams; Jing J Lee; Erwin Berthier; Ashleigh B Theberge
Journal:  Anal Chem       Date:  2021-09-21       Impact factor: 8.008

2.  Accuracy and tolerability of self-sampling of capillary blood for analysis of inflammation and autoantibodies in rheumatoid arthritis patients-results from a randomized controlled trial.

Authors:  Johannes Knitza; Koray Tascilar; Nicolas Vuillerme; Ekaterina Eimer; Paul Matusewicz; Giulia Corte; Louis Schuster; Timothée Aubourg; Gerlinde Bendzuck; Marianne Korinth; Corinna Elling-Audersch; Arnd Kleyer; Sebastian Boeltz; Axel J Hueber; Gerhard Krönke; Georg Schett; David Simon
Journal:  Arthritis Res Ther       Date:  2022-05-25       Impact factor: 5.606

3.  Performance of Dried Blood Spot Samples in SARS-CoV-2 Serolomics.

Authors:  Rima Jeske; Uta Merle; Barbara Müller; Tim Waterboer; Julia Butt
Journal:  Microorganisms       Date:  2022-06-29

4.  How the COVID-19 pandemic is changing clinical trial conduct and driving innovation in bioanalysis.

Authors:  Melanie Anderson
Journal:  Bioanalysis       Date:  2021-07-19       Impact factor: 2.681
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.